PPARD and obesity disorder: The acute treatment of Leprdb/db mice with a PPAR-β/δ agonist reduces lipid accumulation, whereas PPAR-β/δ-deficient mice challenged with HFD show reduced UCP-1 gene expression and were susceptible to obesity [153].